V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004803 | 290003513 | 0 | 83.1 | null | 2017-04-18 | 2017-05-14 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 290021820 | CAPECITABINE + RT |
| 290004804 | 290003514 | 1.57 | 101.15 | Adjuvant (A) | 2018-01-01 | 2018-01-01 | Capecitabine | 99 | N | 290021822 | CAPECITABINE |
| 290004805 | 290003515 | 1.58 | 87.6 | Palliative (P) | 2015-03-18 | 2015-03-18 | Capecitabine (14 days)+Carboplatin | 02 | N | 290021824 | CAPECITABINE |
| 290004806 | 290003516 | 0 | 67 | Palliative (P) | 2015-05-21 | 2015-05-21 | Capecitabine | 02 | N | 290021827 | CISPLATIN + GEMCITABINE |
| 290004807 | 290003516 | 1.74 | 65.8 | Adjuvant (A) | 2017-05-08 | 2017-05-08 | Capecitabine | 2 | null | 290021827 | TRIAL |
| 290004808 | 290003516 | 1.75 | 56 | null | 2016-11-16 | 2016-11-24 | Carboplatin AUC 6 - 10 | 02 | N | 290021827 | CARBOPLATIN + PACLITAXEL |
| 290004809 | 290003517 | 1.81 | 86 | Palliative (P) | 2014-06-19 | 2014-06-20 | CAPECITABINE + RT | 02 | N | 290021838 | CAPECITABINE + RT |
| 290004810 | 290003518 | null | 0 | null | 2016-06-29 | 2016-07-13 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | 290021841 | FLUOROURACIL |
| 290004811 | 290003519 | null | null | Neo-adjuvant (N) | 2016-06-19 | 2016-06-19 | CETUXIMAB | N | N | 290021842 | IRINOTECAN + MDG |
| 290004812 | 290003520 | null | 75.6 | Curative (C) | 2016-03-01 | 2016-03-19 | Gemcitabine + Methylprednisolone | N | Y | 290021847 | CARBOPLATIN + RT |
| 290004813 | 290003521 | null | 60.2 | Palliative (P) | 2016-05-26 | 2016-05-30 | Capecitabine | N | N | 290021848 | CISPLATIN + FLUOROURACIL + RT |
| 290004814 | 290003522 | 1.88 | 67.6 | Palliative (P) | 2014-07-30 | 2014-07-30 | ECF | 2 | null | 290021849 | CARBOPLATIN + ETOPOSIDE |
| 290004815 | 290003523 | 1.77 | 72.9 | Curative (C) | 2013-11-20 | 2017-03-24 | OCTREOTIDE | 02 | N | 290021850 | GEMCITABINE |
| 290004816 | 290003524 | 1.66 | 60.5 | Palliative (P) | 2014-11-30 | 2014-12-04 | Irinotecan + Modified De Gramont | 02 | N | 290021851 | CARBOPLATIN + ETOPOSIDE |
| 290004817 | 290003525 | 1.68 | 56.15 | Palliative (P) | null | 2013-09-19 | Gemcitabine weekly | null | N | 290021852 | CAPECITABINE + RT |
| 290004818 | 290003526 | 1.65 | 58.6 | Disease modification (D) | 2014-06-24 | 2014-07-12 | FLUOROURACIL | N | N | 290021853 | OCTREOTIDE |
| 290004819 | 290003527 | 1.54 | 93 | Palliative (P) | 2015-10-08 | 2015-10-17 | EOX | N | N | 290021857 | ECX |
| 290004820 | 290003528 | 0 | 53.8 | 5 | 2016-11-08 | 2016-11-20 | EOX | 02 | null | 290021858 | GEMCARBO |
| 290004821 | 290006557 | 1.58 | 71.8 | Palliative (P) | null | 2016-06-10 | CARBOPLATIN + GEMCITABINE | N | N | 290021860 | FLUOROURACIL |
| 290004822 | 290003529 | 1.75 | 70.5 | Neo-adjuvant (N) | 2014-12-07 | 2014-12-08 | Cetuximab + Radiotherapy Load | 2 | N | 290021862 | CAPECITABINE + CARBOPLATIN |
| 290004823 | 290003530 | 1.66 | 68.4 | Palliative (P) | 2017-05-14 | 2017-05-28 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | N | 290021863 | CARBOPLATIN + ETOPOSIDE |
| 290004824 | 290003531 | null | 72.7 | Palliative (P) | 2017-03-27 | 2017-03-28 | CYCLOPHOSPHAMIDE | N | N | 290021864 | CAPECITABINE |
| 290004825 | 290003532 | 1.69 | 100.2 | Neo-adjuvant (N) | 2014-09-22 | 2014-09-22 | CAPECITABINE + RT | 2 | N | 290021868 | GEMCITABINE |
| 290004826 | 290006558 | null | 89.6 | Palliative (P) | 2013-01-29 | 2013-02-07 | Cisplatin + Vinorelbine (IV) | N | N | 290021869 | CAPECITABINE + RT |
| 290004827 | 290006558 | 1.6 | 66.5 | Palliative (P) | 2013-05-19 | 2013-05-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 290021869 | CETUXIMAB + CISPLATIN + FU |
| 290004828 | 290003533 | 1.65 | 88.9 | Curative (C) | 2014-05-01 | 2014-05-23 | EOX | 02 | Y | 290021872 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004829 | 290003534 | 1.6 | 47 | Adjuvant (A) | 2015-02-20 | 2015-03-03 | EOX | N | Y | 290021876 | OCTREOTIDE |
| 290004830 | 290003535 | 1.69 | 61.1 | Disease modification (D) | 2016-10-09 | 2016-10-26 | Capecitabine | N | N | 290021877 | OCTREOTIDE |
| 290004831 | 290003536 | 1.68 | 84 | Adjuvant (A) | 2017-10-04 | 2017-10-04 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 290021878 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290004832 | 290003536 | 1.69 | null | Palliative (P) | 2016-08-10 | 2016-08-18 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290021878 | CHOP R |
| 290004833 | 290003536 | 1.68 | 83.6 | Palliative (P) | 2017-09-25 | 2017-10-14 | LANREOTIDE | N | N | 290021878 | IRINOTECAN + MDG |
| 290004834 | 290003537 | 1.62 | null | Curative (C) | 2014-08-01 | 2014-08-18 | Cisplatin +Fluorouracil (3 wk) | N | N | 290021881 | FLUOROURACIL |
| 290004835 | 290003538 | 1.66 | 72 | Palliative (P) | 2018-12-07 | 2018-12-20 | CAPECITABINE + CARBOPLATIN | N | N | 290021882 | FCIST |
| 290004836 | 290003539 | 1.78 | 36 | Curative (C) | 2018-03-17 | 2018-04-05 | CARBOPLATIN + RT | Y | Y | 290021885 | LANREOTIDE |
| 290004837 | 290003540 | null | 71.2 | Curative (C) | 2017-10-25 | 2017-10-31 | Carboplatin + Paclitaxel (3 weekly) | N | N | 290021886 | CISPLATIN + FLUOROURACIL |
| 290004838 | 290003541 | 1.54 | 59.2 | Curative (C) | 2015-02-21 | 2015-03-20 | Capecitabine 35days + RT | 01 | Y | 290021890 | MCX |
| 290004839 | 290003542 | 1.8 | 80.3 | Curative (C) | 2015-03-04 | 2015-03-04 | EOX | 02 | null | 290021891 | CAPECITABINE |
| 290004840 | 290003543 | 1.7 | 95 | Curative (C) | 2013-12-28 | 2013-12-28 | Capecitabine | 2 | N | 290021892 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004841 | 290003543 | 1.69 | 75.2 | Adjuvant (A) | 2016-09-06 | 2016-09-14 | FEC 60 or 75 | 02 | N | 290021892 | CISPLATIN + FLUOROURACIL |
| 290004842 | 290003544 | 1.68 | 75 | Palliative (P) | 2018-08-10 | 2018-08-11 | Capecitabine 35days + RT | 2 | N | 290021897 | CISPLATIN + FLUOROURACIL |
| 290004843 | 290003545 | 1.59 | 50 | Palliative (P) | 2015-02-21 | 2015-02-21 | LANREOTIDE | 02 | null | 290021898 | ECX |
| 290004844 | 290006561 | 1.69 | 56.2 | Palliative (P) | 2013-04-12 | 2013-04-18 | CISPLATIN + FLUOROURACIL | 02 | N | 290021899 | CETUXIMAB + CISPLATIN + FU |
| 290004845 | 290003546 | null | null | null | 2017-07-21 | 2017-07-21 | GemCarbo Days 1+8 | N | N | 290021900 | CETUXIMAB + RT |
| 290004846 | 290003547 | 0 | 71 | Palliative (P) | 2014-09-13 | 2014-09-27 | CARBOPLATIN + RT | N | N | 290021901 | CARBOPLATIN + ETOPOSIDE |
| 290004847 | 290003547 | 1.66 | 71 | Neo-adjuvant (N) | 2013-04-20 | 2013-07-06 | EOX | 02 | N | 290021901 | GEMCITABINE |
| 290004848 | 290003548 | 1.73 | 60 | Palliative (P) | 2016-03-03 | 2016-03-07 | Carboplatin + Paclitaxel (weekly) | 02 | N | 290021905 | CAPECITABINE + RT |
| 290004849 | 290003549 | null | 54.2 | Adjuvant (A) | null | 2016-08-21 | CARBOPLATIN + RT | null | null | 290021906 | CAPECITABINE + RT |
| 290004850 | 290003550 | 1.6 | 99.9 | Palliative (P) | 2016-07-24 | 2016-08-04 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 290021908 | CETUXIMAB + CISPLATIN + FU |
| 290004851 | 290003551 | 1.62 | 72.8 | Neo-adjuvant (N) | 2016-02-03 | 2016-02-25 | Hydroxycarbamide | 2 | N | 290021911 | CAPECITABINE + RT |
| 290004852 | 290003552 | 1.6 | 74.7 | Curative (C) | 2014-03-20 | 2014-04-16 | Capecitabine 35days + RT | N | Y | 290021913 | CISPLATIN + FLUOROURACIL + RT |